The biology of prostate cancer: new and future directions in predicting tumor behavior.

Research output: Contribution to journalArticle

Abstract

Because the present ability to treat and cure patients with prostate cancer is limited to those patients with pathologically organ-confined disease, it has become increasingly important to diagnose this disease at an early stage when cure is most likely. Recent advances in imaging may allow the urologist and pathologist to make the diagnosis of prostate cancer much earlier in the natural course of the disease. It therefore becomes imperative to have methods available to predict which patients have a high probability of progressing so that treatment can be assigned logically and appropriately. Our current methods of prognosis determination (stage and grade) do not allow accurate assessment of tumor behavior in the majority of individual patients with prostate cancer. Therefore, more accurate quantification of nuclear and cellular changes that take place as a tumor progresses to take on the aggressive (metastatic) phenotype are urgently needed. Experimental techniques have proven useful in answering these questions in animal models and now seem ready for large-scale testing in clinical studies.

Original languageEnglish (US)
Pages (from-to)198-218
Number of pages21
JournalMonographs in pathology
Issue number34
StatePublished - 1992
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Neoplasms
Animal Models
Phenotype
Direction compound
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{1713c1d636b341bf85758933681b45b1,
title = "The biology of prostate cancer: new and future directions in predicting tumor behavior.",
abstract = "Because the present ability to treat and cure patients with prostate cancer is limited to those patients with pathologically organ-confined disease, it has become increasingly important to diagnose this disease at an early stage when cure is most likely. Recent advances in imaging may allow the urologist and pathologist to make the diagnosis of prostate cancer much earlier in the natural course of the disease. It therefore becomes imperative to have methods available to predict which patients have a high probability of progressing so that treatment can be assigned logically and appropriately. Our current methods of prognosis determination (stage and grade) do not allow accurate assessment of tumor behavior in the majority of individual patients with prostate cancer. Therefore, more accurate quantification of nuclear and cellular changes that take place as a tumor progresses to take on the aggressive (metastatic) phenotype are urgently needed. Experimental techniques have proven useful in answering these questions in animal models and now seem ready for large-scale testing in clinical studies.",
author = "Partin, {Alan Wayne} and Carter, {H Ballentine} and Epstein, {Jonathan Ira} and Coffey, {D. S.}",
year = "1992",
language = "English (US)",
pages = "198--218",
journal = "Monographs in pathology",
issn = "0077-0922",
publisher = "Williams & Wilkins Co.",
number = "34",

}

TY - JOUR

T1 - The biology of prostate cancer

T2 - new and future directions in predicting tumor behavior.

AU - Partin, Alan Wayne

AU - Carter, H Ballentine

AU - Epstein, Jonathan Ira

AU - Coffey, D. S.

PY - 1992

Y1 - 1992

N2 - Because the present ability to treat and cure patients with prostate cancer is limited to those patients with pathologically organ-confined disease, it has become increasingly important to diagnose this disease at an early stage when cure is most likely. Recent advances in imaging may allow the urologist and pathologist to make the diagnosis of prostate cancer much earlier in the natural course of the disease. It therefore becomes imperative to have methods available to predict which patients have a high probability of progressing so that treatment can be assigned logically and appropriately. Our current methods of prognosis determination (stage and grade) do not allow accurate assessment of tumor behavior in the majority of individual patients with prostate cancer. Therefore, more accurate quantification of nuclear and cellular changes that take place as a tumor progresses to take on the aggressive (metastatic) phenotype are urgently needed. Experimental techniques have proven useful in answering these questions in animal models and now seem ready for large-scale testing in clinical studies.

AB - Because the present ability to treat and cure patients with prostate cancer is limited to those patients with pathologically organ-confined disease, it has become increasingly important to diagnose this disease at an early stage when cure is most likely. Recent advances in imaging may allow the urologist and pathologist to make the diagnosis of prostate cancer much earlier in the natural course of the disease. It therefore becomes imperative to have methods available to predict which patients have a high probability of progressing so that treatment can be assigned logically and appropriately. Our current methods of prognosis determination (stage and grade) do not allow accurate assessment of tumor behavior in the majority of individual patients with prostate cancer. Therefore, more accurate quantification of nuclear and cellular changes that take place as a tumor progresses to take on the aggressive (metastatic) phenotype are urgently needed. Experimental techniques have proven useful in answering these questions in animal models and now seem ready for large-scale testing in clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=0026449612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026449612&partnerID=8YFLogxK

M3 - Article

C2 - 1406742

AN - SCOPUS:0026449612

SP - 198

EP - 218

JO - Monographs in pathology

JF - Monographs in pathology

SN - 0077-0922

IS - 34

ER -